Enhancing Genomic Analysis with Next-Generation Phenotyping (NGP)
FDNA’s NGP technologies aid in the capturing, structuring, and analysis of phenotypic data, creating a deeper level of evaluation and understanding for more accurate genomic insights. Integration or interoperability with these technologies within third-party platforms or software solutions enhances phenotyping for clinical management, clinical trial recruitment, lab information management, and genomic analysis, among other benefits.
Recent studies show that when NGP technologies are combined with next-generation sequencing (NGS) analysis tools, the diagnostic yield increases to 98% with top-10 accuracy, (Prioritization of Exome Data by Image Analysis ‘PEDIA’). Together, these technologies can unlock genomic insights that improve personalized care.